Sipai Health Technology Outlines Board and Committee Composition

The latest update is out from Sipai Health Technology Co., Ltd. ( (HK:0314) ).

Sipai Health Technology has announced the current composition of its board of directors and the allocation of roles across four key board committees. The board is led by executive chairman Ma Xuguang alongside executive director Li Ji, non-executive director Yao Leiwen and three independent non-executive directors, who collectively chair and staff the audit, remuneration and appraisal, nomination and strategy committees. The disclosure underscores the company’s corporate governance framework, highlighting independent oversight of audit and remuneration matters and a defined distribution of responsibilities that may reassure investors about board independence and strategic supervision.

The most recent analyst rating on (HK:0314) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Sipai Health Technology Co., Ltd. stock, see the HK:0314 Stock Forecast page.

More about Sipai Health Technology Co., Ltd.

Sipai Health Technology Co., Ltd. is a Cayman Islands–incorporated company listed in Hong Kong (stock code: 0314). The company operates in the health technology sector, with its governance structure overseen by a board comprising executive, non-executive and independent non-executive directors, supported by four specialized board committees for audit, remuneration and appraisal, nomination, and strategy.

Average Trading Volume: 1,076,230

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.82B

For a thorough assessment of 0314 stock, go to TipRanks’ Stock Analysis page.